Statins studied to fight bone loss and heart risk after paralysis
NCT ID NCT03113994
First seen Apr 17, 2026 · Last updated May 22, 2026 · Updated 4 times
Summary
This study aimed to see if the statin drug rosuvastatin could help prevent bone loss and reduce heart disease risk in adults with long-term spinal cord injury. Participants took either rosuvastatin or a placebo, plus supplements, for 12 months. The study was terminated early and enrolled only 8 of the planned 54 participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University Health Network - Toronto Rehab Lyndhurst Centre
Toronto, Ontario, M4G 3V9, Canada
-
University Of Miami Miller School of Medicine
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.